7.94
0.63 (8.62%)
0.63 (8.62%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Scynexis Inc | SCYX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.63 | 8.62% | 7.94 | 19:59:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.86 | 7.62 | 9.15 | 8.11 | 7.31 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 7.94 | 8.01 | 0.07 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 52,039 | 8,401,971 | $ 8.06 | $ 67,751,356 | 390,987 | 0.50 - 9.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:49 | 82 | $ 7.94 | USD |
Scynexis Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 153.08M | 19.28M | 17.32M | $ 121.00k | $ - | -9.79 | -2.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 58.65k | 2.20% |
Scynexis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SCYX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.95 | 9.15 | 7.21 | 7.61 | 491,587 | -0.01 | -0.13% |
| 1 Month | 7.28 | 9.15 | 6.88 | 7.56 | 409,720 | 0.66 | 9.07% |
| 3 Months | 4.33 | 9.15 | 4.25 | 6.94 | 286,193 | 3.61 | 83.37% |
| 6 Months | 7.05 | 9.15 | 4.2009 | 6.61 | 166,496 | 0.89 | 12.62% |
| 1 Year | 1.04 | 9.15 | 0.50 | 1.73 | 560,192 | 6.90 | 663.46% |
| 3 Years | 1.85 | 9.15 | 0.35 | 1.39 | 598,721 | 6.09 | 329.19% |
| 5 Years | 4.855 | 9.15 | 0.35 | 1.78 | 494,731 | 3.09 | 63.54% |
Scynexis Description
| SCYNEXIS Inc is drug development company which focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. It is engaged in developing lead product candidate, SCY-078 which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The SCY-078 is a novel and structurally distinct triterpenoid glucan synthase inhibitor which is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains. |
